Evaluation of the relevance of Embase for searches for drug trials

Report documents

1. Extract of the working paper

   Evaluation of the relevance of Embase for searches for drug trials

   published on

   10.12.2025

   Document type

   PDF document, 177 kB, DE, not accessible

   Download file : Extract of the working paper (PDF document, 177 kB, DE, not accessible)
2. Working paper

   Evaluation of the relevance of Embase for searches for drug trials

   published on

   10.12.2025

   Document type

   PDF document, 352 kB, EN, not accessible

   DOI-Link

   https://doi.org/10.60584/GA24-04_en

   Download file : Working paper (PDF document, 352 kB, EN, not accessible)

Project details

Project no.

GA24-04

Report type

Working paper

Status

Commission completed

Department/Division

Information Management

Note

Information retrieval for the preparation of systematic reviews of pharmacological interventions has changed considerably over the past 20 years. This is largely due to the legal obligation in the USA (since 2007) and EU (since 2011) to register almost all clinical studies and then to promptly publish the results.

Embase is a bibliographical database comprising more than 36 million data records and 8500 journals. Since searching and screening in Embase is very time-consuming due to the high number of hits, and at the same time experience shows that only very few additional publications are found via Embase, this general commission analyses internally available data in order to investigate the value of Embase for IQWiG benefit assessments.

DOI

https://doi.org/10.60584/GA24-04_en